STAT Plus: A small drug maker accuses Soon-Shiong of masterminding a ‘catch-and-kill’ scheme
DARREN MCCOLLESTER/GETTY IMAGES
At issue is a deal that took place four years ago for a chemotherapy that Sorrento Therapeutics was developing to rival Abraxane sold by Celgene.
.png)
No hay comentarios:
Publicar un comentario